Delivery Order SPE2DB22D2006-SPE2DB24FW0QD
Award Date
5/23/24
Potential Completion Date
5/24/24
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 12.5 mg/0.5 mL pens. The contract, valued at $1,578.00, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price pricing type. The contract has an ultimate completion date of November 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is the prime contractor, and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,321.04, is for the procurement of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed-price pricing type and an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has a firm fixed price of $5,189.64 and a completion date of August 1, 2024. This is a delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between AmerisourceBergen and the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens, with a total ceiling value of $11,971.96 and a completion date of March 20, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under contract SPE2DB20D2104|SPE2DB25FMCPD. The $1,533.35 firm fixed-price delivery order is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens to support federal healthcare programs. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (Tirzepatide) 10 mg/0.5 ml pen. The contract has a ceiling value of $15,911.28 and runs through November 20, 2024. The contract was not set aside for any specific business type. AmerisourceBergen is the prime contractor, and the contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a ceiling value of $17,357.67 and an ultimate completion date of July 31, 2024. This award is placed against a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999, which...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The award, valued at $1,578, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a ceiling value of $20,165.02 and a period of performance through October 26, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...